Search results for "Period Analysis"

showing 5 items of 5 documents

Survival of stomach and esophagus cancer patients in Germany in the early 21st century

2012

Esophagus and stomach cancers are associated with poor prognosis. But most published population-based cancer survival estimates for stomach and esophagus cancer refer to survival experience of patients diagnosed in the 1990s or earlier years. The aim of this study was to provide up-to-date survival estimates and trends for patients with stomach and esophagus cancer in Germany.Our analysis is based on data from 11 population-based cancer registries, covering 33 million inhabitants. Patients diagnosed with stomach and esophagus cancer in 1997-2006 were included. Period analysis was used to derive five-year relative survival estimates and trends by age, sex, cancer subsite, and stage for the t…

AdultMalemedicine.medical_specialtyEsophageal NeoplasmsPopulationAdenocarcinomaGastroenterologyStomach NeoplasmsGermanyInternal medicinemedicineHumansRadiology Nuclear Medicine and imagingRegistriesSex DistributionEsophagusStage (cooking)educationSurvival analysisAgededucation.field_of_studyRelative survivalbusiness.industryStomachCancerHematologyGeneral MedicineMiddle Agedmedicine.diseaseSurvival AnalysisUnited StatesSurvival Ratemedicine.anatomical_structureOncologyPeriod AnalysisFemaleEsophagogastric JunctionbusinessSEER ProgramActa Oncologica
researchProduct

Survival of patients with non-Hodgkin lymphoma in Germany in the early 21st century.

2012

This study provides up-to-date and detailed cancer survival estimates of German patients with non-Hodgkin lymphoma (NHL, International Statistical Classification of Diseases 10th Revision [ICD-10] codes C82-C85) based on data from 11 cancer registries. Period analysis was used to calculate 5-year relative survival in 2002-2006, overall and by gender, age and histology. Comparison was made with patients with NHL in the United States (US) Surveillance, Epidemiology and End Results database in the same time period. Overall 5-year relative survival for patients with NHL in Germany in 2002-2006 was 62.8% and in the US was 65.1%. Survival decreased with age from 81.7% at age 15-49 to 46.5% at age…

AdultMaleCancer Researchmedicine.medical_specialtyAdolescentFollicular lymphomaHistory 21st CenturyYoung AdultOlder patientshemic and lymphatic diseasesInternal medicineGermanyEpidemiologymedicineHumansRegistriesAgedAged 80 and overRelative survivalbusiness.industryLymphoma Non-HodgkinCancerHematologyHistory 20th CenturyMiddle Agedmedicine.diseaseUnited StatesLymphomaOncologyImmunologyPeriod AnalysisHodgkin lymphomaFemalebusinessSEER ProgramLeukemialymphoma
researchProduct

Recent Trends in Survival of Patients With Pancreatic Cancer in Germany and the United States

2016

Objectives Survival improvement for pancreatic cancer has not been observed in the last 4 decades. We report the most up-to-date population-based relative survival (RS) estimates and recent trends in Germany and the United States. Methods Data for patients diagnosed in 1997 to 2010 and followed up to 2010 were drawn from 12 population-based German cancer registries and the US SEER (Surveillance, Epidemiology and End Results) 13 registries database. Using period analysis, 5-year RS for 2007 to 2010 was derived. Model-based period analysis was used to assess 5-year RS time trends, 2002-2010. Results In total 28,977 (Germany) and 34,793 (United States) patients aged 15 to 74 years were analyze…

AdultMalemedicine.medical_specialtyPathologyAdolescentEndocrinology Diabetes and MetabolismPopulationYoung Adult03 medical and health sciencesAge DistributionSex Factors0302 clinical medicineEndocrinologyGermanyPancreatic cancerEpidemiologyInternal MedicineHumansMedicineRegistriesYoung adulteducationSurvival analysisAgedNeoplasm StagingAged 80 and overeducation.field_of_studyHepatologyRelative survivalbusiness.industryAge FactorsCancerMiddle AgedPrognosismedicine.diseaseSurvival AnalysisUnited StatesPancreatic NeoplasmsSurvival Rate030220 oncology & carcinogenesisPeriod AnalysisFemale030211 gastroenterology & hepatologybusinessSEER ProgramDemographyPancreas
researchProduct

Survival from colorectal cancer in Germany in the early 21st century.

2012

Background: Colorectal cancer is the most common cancer in Germany and the second most common cause of cancer-related deaths in both men and women. The aim of this study is to provide detailed analysis of recent developments in survival of colorectal cancer patients using newly available data on a national basis. Methods: We included data from 11 German cancer registries covering a population of 33 million inhabitants. Period analysis and modelled period analysis were used to provide most up-to-date estimates of 5-year relative survival in 2002–2006. Results: The analysis was based on records of 164 996 colorectal cancer patients. Five-year relative survival was 63.0% overall, decreased wit…

OncologyAdultMaleCancer Researchmedicine.medical_specialtyAdolescentColorectal cancerEpidemiologyPopulationcolorectal cancersurvivalperiod analysis03 medical and health sciencesYoung Adult0302 clinical medicineAge DistributionInternal medicineGermanymorphologymedicineCarcinomaHumansRegistriesYoung adulteducationSurvival analysissubsiteAgededucation.field_of_studyRelative survivalbusiness.industryCarcinomaCancerMiddle Agedmedicine.diseaseSurvival Analysis3. Good healthOncology030220 oncology & carcinogenesisPeriod Analysis030211 gastroenterology & hepatologyFemalebusinessColorectal NeoplasmsBritish journal of cancer
researchProduct

Improved population level survival in younger Hodgkin lymphoma patients in Germany in the early 21st century.

2013

Summary Treatment for Hodgkin lymphoma (HL) is more aggressive in Germany than in the United States (US) and differences in treatment may lead to differences in population level survival. Patients diagnosed with HL in 11 German states in 1997–2006 were included in the analyses and were compared to similar analyses from patients in the Surveillance, Epidemiology, and End Results database in the US. Period analysis was used to calculate 5-year relative survival for the time period of 2002–2006 overall and by gender, age and histology. Overall 5-year relative survival for patients with HL in Germany was 84·3%, compared to 80·6% for the US. Survival was highest in patients aged 15–29 years at 9…

AdultMalemedicine.medical_specialtyPediatricsPopulation levelPopulationLate toxicityOlder patientsGermanyEpidemiologyMedicineHumanseducationeducation.field_of_studyRelative survivalbusiness.industryAge FactorsHematologyMiddle AgedHodgkin DiseaseSurvival AnalysisSurvival RateHodgkin lymphomaPeriod AnalysisFemalebusinessBritish journal of haematology
researchProduct